BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 14966521)

  • 1. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
    Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
    Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.
    Park JB; Yiu G; Kaneko S; Wang J; Chang J; He XL; Garcia KC; He Z
    Neuron; 2005 Feb; 45(3):345-51. PubMed ID: 15694321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
    Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
    Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
    Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
    Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
    Saha N; Kolev M; Nikolov DB
    Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways.
    Palandri A; Salvador VR; Wojnacki J; Vivinetto AL; Schnaar RL; Lopez PH
    Cell Death Dis; 2015 Sep; 6(9):e1876. PubMed ID: 26335717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments.
    Meabon JS; De Laat R; Ieguchi K; Wiley JC; Hudson MP; Bothwell M
    J Biol Chem; 2015 Apr; 290(15):9511-20. PubMed ID: 25666623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroscience. It takes more than two to Nogo.
    Woolf CJ; Bloechlinger S
    Science; 2002 Aug; 297(5584):1132-4. PubMed ID: 12183616
    [No Abstract]   [Full Text] [Related]  

  • 11. Axon regeneration: it's getting crowded at the gates of TROY.
    Mandemakers WJ; Barres BA
    Curr Biol; 2005 Apr; 15(8):R302-5. PubMed ID: 15854897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nogo on the go.
    McKerracher L; Winton MJ
    Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
    Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
    J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.
    Kwon HS; Nakaya N; Abu-Asab M; Kim HS; Tomarev SI
    J Neurosci; 2014 Apr; 34(16):5539-51. PubMed ID: 24741044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nogo receptor complex: confining molecules to molecular mechanisms.
    Schwab JM; Tuli SK; Failli V
    Trends Mol Med; 2006 Jul; 12(7):293-7. PubMed ID: 16723274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory proteins against axon regeneration in the central nervous system].
    Hu JG; Lu PH; Xu XM
    Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINGO-1 negatively regulates myelination by oligodendrocytes.
    Mi S; Miller RH; Lee X; Scott ML; Shulag-Morskaya S; Shao Z; Chang J; Thill G; Levesque M; Zhang M; Hession C; Sah D; Trapp B; He Z; Jung V; McCoy JM; Pepinsky RB
    Nat Neurosci; 2005 Jun; 8(6):745-51. PubMed ID: 15895088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.
    Robak LA; Venkatesh K; Lee H; Raiker SJ; Duan Y; Lee-Osbourne J; Hofer T; Mage RG; Rader C; Giger RJ
    J Neurosci; 2009 May; 29(18):5768-83. PubMed ID: 19420245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
    Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
    Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.